Aerolin Inhaler

Aerolin Inhaler is a bronchodilator medication primarily used to relieve bronchospasm in conditions such as asthma, chronic obstructive pulmonary disease (COPD), and exercise-induced bronchospasm. The active ingredient, Salbutamol (also known as Albuterol), is a selective β₂-adrenergic agonist that relaxes the muscles in the airways, facilitating easier airflow to the lungs. This medication is available in various formulations, including metered-dose inhalers (MDIs), dry powder inhalers (DPIs), and solutions for nebulization. The inhaler typically delivers 100 micrograms of Salbutamol per actuation, providing rapid relief from acute bronchospasm. Manufacturing of Aerolin Inhaler occurs in multiple countries, including Egypt, where it is produced by Medical Union Pharmaceuticals. (jbiomedsem.biomedcentral.com) The brand is owned by Medical Union Pharmaceuticals, an Egyptian pharmaceutical company specializing in the production of generic medications. As of 2026, the ultimate owner company is Medical Union Pharmaceuticals, headquartered in Egypt. There are no known subsidiaries owning the brand locally; it is distributed directly by the parent company.